A clinical observational study on the efficacy of subcutaneous etonogestrel implants for adenomyosis in 20 patients
- 24 June 2021
- journal article
- research article
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 37 (8) , 735-739
Abstract
Objective: To evaluate the efficacy of subcutaneous etonogestrel implants for adenomyosis. Methods: We conducted a clinical observational study of 20 patients suffering from adenomyosis treated with subcutaneous etonogestrel implants from August 2015 to July 2017 and followed up for 36 months. We evaluated the efficacy of subcutaneous etonogestrel implants primarily based on the following indicators: the pictorial blood loss assessment chart (PBAC) for menstrual blood volume, changes in bleeding patterns, the visual analog scale (VAS) pain score for dysmenorrhea, uterine volume, serum cancer antigen 125 (CA125) levels, hemoglobin levels and side effects. Results: During the 3 years of follow-up, subcutaneous etonogestrel implants were removed from six patients, among whom one was diagnosed with endometrial cancer, four had an increased menstrual blood volume, and one entered menopause. In total, 14 patients were treated with subcutaneous etonogestrel implants for 3 years. Among these patients, the number of patients with heavy menstrual bleeding and high PBAC and VAS scores and serum CA125 levels was significantly decreased after implantation compared with that before implantation. In the eight patients with anemia, hemoglobin levels increased gradually. However, the uterine volumes did not significantly change. Bleeding patterns were changed but were tolerable. Conclusion: Subcutaneous etonogestrel implants represent a new option for the clinical treatment of adenomyosis for patients who refuse surgery.Keywords
Funding Information
- Scientific Research Foundation of Qilu Hospital of Shandong University (QDKY2016LH01)
This publication has 21 references indexed in Scilit:
- An update on adenomyosisDiagnostic and Interventional Imaging, 2013
- Adenomyosis and subfertility: a systematic review of prevalence, diagnosis, treatment and fertility outcomesHuman Reproduction Update, 2012
- Pictorial Blood Loss Assessment Chart in the Evaluation of Heavy Menstrual Bleeding: Diagnostic Accuracy Compared to Alkaline HematinGynecologic and Obstetric Investigation, 2011
- Tolerability and clinical safety of Implanon®The European Journal of Contraception & Reproductive Health Care, 2008
- The effects of Implanon® on menstrual bleeding patternsThe European Journal of Contraception & Reproductive Health Care, 2008
- Safety and efficacy of Implanon™, a single-rod implantable contraceptive containing etonogestrelContraception, 2005
- The Pharmacokinetics and Pharmacodynamics of Implanon®, a Single-Rod Etonogestrel Contraceptive ImplantThe European Journal of Contraception & Reproductive Health Care, 2000
- Ovarian Function During the Use of a Single Contraceptive Implant: Implanon Compared with NorplantFertility and Sterility, 1998
- Assessment of menstrual blood loss using a pictorial chartBJOG: An International Journal of Obstetrics & Gynaecology, 1990
- The analysis of vaginal bleeding patterns induced by fertility regulating methodsContraception, 1986